Co-Authors
This is a "connection" page, showing publications co-authored by Steven Gitelis and Carl Maki.
Connection Strength
0.423
-
The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017 Nov 02; 18(11):895-903.
Score: 0.145
-
Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor. Oncotarget. 2016 May 10; 7(19):27511-26.
Score: 0.134
-
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biol Ther. 2014; 15(12):1600-12.
Score: 0.114
-
Research findings working with the p53 and Rb1 targeted osteosarcoma mouse model. Am J Cancer Res. 2014; 4(3):234-44.
Score: 0.029